The Pharmacy Times® Insights video library presents one-on-one interviews with pharmacy experts, who examine the latest patient counseling tools and innovative solutions for the everyday practice and business.

What can we help you find?
Utilizing a DOAC
Considerations for transitioning patients from heparin over to a direct oral anticoagulant for venous thromboembolism prophylaxis, and strategies that can help health care professionals better manage patients through a drug shortage.
Treating With a DOAC for VTE Prophylaxis
Implications for treating appropriate patients with a direct oral anticoagulant, such as rivaroxaban, based on more recent trial data and a new indication for the prevention of venous thromboembolism.
DOACs Available for VTE Prophylaxis
Dr. Manesh R. Patel and Sarah A. Spinler compare and contrast the direct oral anticoagulants betrixaban and rivaroxaban and remark on variables that impact treatment selection.
Defining Medically Ill Patients for VTE Prophylaxis
Patient factors that can help healthcare professionals determine the appropriateness for administering a direct oral anticoagulant versus heparin for prophylaxis of venous thromboembolism.
Chemo-Induced Nausea & Vomiting
In this series, Bhavesh Shah, RPh, BCOP and Dr. Katharine Lin, PharmD, BCOP provide an in-depth understanding of chemo-induced nausea & vomiting (CINV) and share some common practices for patient management.
Addressing the Heparin Drug Shortage
Dr. Manesh R. Patel and Sarah A. Spinler react to the recent shortage of heparin in the United States and consider how the approval of direct oral anticoagulants can potentially serve as an alternative for appropriate patients.
Navigating Through Drug Shortages
Considerations for managing inventory levels in the pharmacy when navigating through drug shortages.
Drug Shortages in the United States
Sarah A. Spinler highlights common factors that are responsible for drug shortages in the United States and points out available resources that can help educate stakeholders on current drug shortages.
The key opinion leader discusses the patient education needed and how pharmacists can improve their knowledge.
In-Home Drug Testing
Christopher Altman, PharmD, provides an understanding of the in-home drug testing.
Hair Drug-Testing Products
Key opinion leader provides specifics for using the hair drug-testing product with the pros and cons.
Urine Drug-Testing Products
Harshav Raval, PharmD, RPh, details the specifics involved with using the urine drug-testing products.